Jasper Hellweg
Stock Analyst at Argus Research
(4.09)
# 1,562
Out of 4,345 analysts
227
Total ratings
55.3%
Success rate
7.4%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Downgraded: Hold | n/a | $79.48 | - | 12 | May 27, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $220 → $250 | $215.40 | +16.06% | 5 | May 13, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $130 | $120.24 | +8.12% | 5 | May 8, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Buy | $55 | $52.40 | +4.96% | 3 | Apr 6, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | n/a | $44.55 | - | 7 | Mar 20, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $345 → $560 | $570.75 | -1.88% | 11 | Mar 3, 2026 | |
| MRNA Moderna | Reiterated: Hold | n/a | $47.61 | - | 14 | Jan 13, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $196.97 | - | 5 | Jan 9, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | n/a | $57.52 | - | 4 | Jan 7, 2026 | |
| ELAN Elanco Animal Health | Upgraded: Buy | $25 | $23.69 | +5.53% | 6 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 78.34 → CHF 66.59 | $52.76 | +26.22% | 4 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $627.74 | - | 13 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $133.69 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $100 | $150.17 | n/a | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $19.33 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $34.56 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,082.92 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.29 | n/a | 4 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $360 | $336.06 | n/a | 6 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $51.58 | n/a | 1 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $60 | $44.43 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $550 | $437.22 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $125 | $88.97 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $70 | $97.34 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $4.90 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $285 → $225 | $163.69 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $258.25 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $193.99 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $475 → $500 | $391.47 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $290 | $165.62 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $275 | $392.15 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $50 | $50.46 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.00 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $135 | $89.92 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $55.62 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.16 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $236.18 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.30 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $20.03 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $273.67 | n/a | 1 | Aug 31, 2016 |
Zoetis
May 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $79.48
Upside: -
AbbVie
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $215.40
Upside: +16.06%
Merck & Co.
May 8, 2026
Reiterated: Buy
Price Target: $130
Current: $120.24
Upside: +8.12%
Roche Holding AG
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $52.40
Upside: +4.96%
Novo Nordisk
Mar 20, 2026
Maintained: Hold
Price Target: n/a
Current: $44.55
Upside: -
United Therapeutics
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $570.75
Upside: -1.88%
Moderna
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $47.61
Upside: -
Biogen
Jan 9, 2026
Maintained: Hold
Price Target: n/a
Current: $196.97
Upside: -
Bristol-Myers Squibb Company
Jan 7, 2026
Maintained: Hold
Price Target: n/a
Current: $57.52
Upside: -
Elanco Animal Health
Nov 19, 2025
Upgraded: Buy
Price Target: $25
Current: $23.69
Upside: +5.53%
Oct 10, 2025
Maintained: Buy
Price Target: CHF 78.34 → CHF 66.59
Current: $52.76
Upside: +26.22%
Jun 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $627.74
Upside: -
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $133.69
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $150 → $100
Current: $150.17
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $19.33
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: $20
Current: $34.56
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: n/a
Current: $1,082.92
Upside: n/a
Jan 6, 2025
Maintained: Hold
Price Target: n/a
Current: $16.29
Upside: n/a
Aug 20, 2024
Maintained: Buy
Price Target: $340 → $360
Current: $336.06
Upside: n/a
Aug 6, 2024
Rated: Buy
Price Target: n/a
Current: $51.58
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $55 → $60
Current: $44.43
Upside: n/a
Jun 17, 2024
Maintained: Buy
Price Target: $465 → $550
Current: $437.22
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $105 → $125
Current: $88.97
Upside: n/a
Apr 25, 2024
Maintained: Buy
Price Target: $90 → $70
Current: $97.34
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $4.90
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $285 → $225
Current: $163.69
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $258.25
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $135 → $165
Current: $193.99
Upside: n/a
Feb 7, 2022
Maintained: Buy
Price Target: $475 → $500
Current: $391.47
Upside: n/a
Sep 10, 2021
Maintained: Buy
Price Target: $260 → $290
Current: $165.62
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $195 → $275
Current: $392.15
Upside: n/a
Jun 7, 2021
Maintained: Buy
Price Target: $43 → $50
Current: $50.46
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $9.00
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $95 → $135
Current: $89.92
Upside: n/a
Jun 12, 2020
Maintained: Buy
Price Target: $135 → $115
Current: $55.62
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $11.16
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $236.18
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $29.30
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $20.03
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $273.67
Upside: n/a